Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 11 citing Tedesco: Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endotheli.... (0.08 sec) 

Should peripheral CB1 cannabinoid receptors be selectively targeted for …

- nih.gov
G Kunos, D Osei-Hyiaman, S Bátkai, KA Sharkey, A … - Trends in pharmacological …, 2009 - Elsevier
Endocannabinoids, endogenous lipid ligands of cannabinoid receptors, mediate a variety of
effects similar to those of marijuana. Cannabinoid CB 1 receptors are highly abundant in the
brain and mediate psychotropic effects, which limits their value as a potential therapeutic ...
Cited by 12 - Related articles - All 7 versions

Adiponectin is required to mediate rimonabant-induced improvement of insulin …


S Migrenne, A Lacombe, AL Lefevre, MP … - American Journal of …, 2009 - Am Physiological Soc
The increase in adiponectin levels in obese patients with untreated dyslipidemia and its mRNA
expression in adipose tissue of obese animals are one of the most interesting consequences
of rimonabant treatment. Thus, part of rimonabant's metabolic effects could be related to ...
Cited by 5 - Related articles - All 3 versions

Different Transcriptional Control of Metabolism and Extracellular Matrix in Visceral …


C Poussin, D Hall, K Minehira, AM Galzin, D … - PLoS ONE, 2008 - pubmedcentral.nih.gov
C57Bl/6 mice fed a high fat diet (HFD) for 6 months developed low, medium, or high body weight
as compared to normal chow fed mice. Mice from each groups were then treated with the cannabinoid
receptor 1 antagonist rimonabant or vehicle for 24 days to normalize their body weight. ...
Cited by 1 - Related articles - All 5 versions

[PDF] Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin …


AVW Nunn, JD Bell, GW Guy - Nutrition & Metabolism, 2009 - biomedcentral.com
Address: 1Metabolic and Molecular Imaging Group, MRC Clinical Sciences Centre, Hammersmith
Hospital, Imperial College London, Du Cane Road, London, W12 OHS, UK and 2GW
pharmaceuticals, Porton Down, Dorset, UK Email: Alistair VW Nunn* - alistair.nunn@ ...
Cited by 1 - Related articles - View as HTML - All 7 versions

Mitochondrial DNA content in peripheral blood monocytes: relationship with age of …


J Wong, SV McLennan, L Molyneaux, D Min, SM Twigg … - Diabetologia, 2009 - Springer
Abstract Aims/hypothesis We examined whether age of type 2 dia- betes onset is related to mitochondrial
DNA content in peripheral blood monocytes (PBMCs). Methods PBMCs were isolated from 65
patients with type 2 diabetes. To minimise age as a confounder, only patients aged ≥50 ...
Related articles - All 2 versions

[PDF] Different Transcriptional Control of Metabolism and Extracellular Matrix in Visceral …


C Poussin, D Hall, K Minehira, AM Galzin, D Tarussio… - 2008 - my.unil.ch
Methodology: C57Bl/6 mice fed a high fat diet (HFD) for 6 months developed low, medium, or
high body weight as compared to normal chow fed mice. Mice from each groups were then treated
with the cannabinoid receptor 1 antagonist rimonabant or vehicle for 24 days to normalize ...
Related articles - View as HTML

Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial …


M Flamment, N Gueguen, C Wetterwald, G … - American Journal of …, 2009 - Am Physiological Soc
The aim of this study was to investigate the effect of rimonabant treatment on hepatic mitochondrial
function in rats fed a high-fat diet. Sprague-Dawley rats fed a high-fat diet (35% lard) for 13 wk
were treated with rimonabant (10 mg·kg –1 ·day –1 ) during the last 3 wk and matched ...
Related articles - All 3 versions

Cannabinoid Receptor CB1 Antagonists: State of the Art and Challenges


AM Malfitano - Anandamide, 2009 - books.google.com
> CHAPTER SEVEN Cannabinoid Receptor CB1 Antagonists: State of the Art and Challenges
Maurizio Bifulco,* Antonietta Santoro,* Chiara Laezza,+ and Anna Maria Malfitano* Contents
I. Introduction 160 II. Endocannabinoid System: Control of Energy Balance 161 III. ...
Related articles

Feeding Disorders and Obesity


C Cervino, V Vicennati, R Pasquali, U Pagotto - Behavioral Neurobiology of the …, 2009 - Springer
Abstract The ability of the endocannabinoid (EC) system to control appetite, food intake and energy
balance has recently received great attention, particularly in the light of the different modes of
action underlying these functions. The EC system modulates rewarding properties of food ...
Related articles - All 2 versions

[PDF] THE ENDOCANNABINOID SYSTEM IN ADIPOSE TISSUE


U Pagotto - Pathogenesis of the metabolic syndrome and … - cmrejournal.cardiometabolic-risk.org
31 December 2008 (Vol. 1, Issue 3, pages 31-35) THE ENDOCANNABINOID SYSTEM IN ADIPOSE
TISSUE By Uberto Pagotto, MD, PhD Endocrinology Unit and Center of Applied Biomedical Research
(CRBA), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi ...
Related articles - View as HTML - All 2 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google